Within artificial intelligence and machine learning, a generative model is a powerful tool for learning any kind of data distribution. With the advent of deep learning and its success in image recognition, the field of deep generative models has clearly emerged as one of the promising fields for medical imaging. In a recent issue of The Journal of Pathology, Levine, Peng et al demonstrate the ability of generative models to synthesize high-quality pathology images. https://www.selleckchem.com/products/monocrotaline.html They suggested that generative models can serve as an unlimited source of images either for educating freshman pathologists or training machine learning models for diverse image analysis tasks, especially in scarce cases, while resolving patients' privacy and confidentiality concerns. © 2020 The Pathological Society of Great Britain and Ireland. Published by John Wiley &amp; Sons, Ltd.In this study a simplified temperature model for raceway reactors is developed, allowing to determine the temperature of the microalgae culture as a function of reactor design and environmental conditions. The model considers the major phenomena taking place in raceway reactors, especially heat absorption by radiation and heat losses by evaporation among others. The characteristic parameters of the model have been calibrated using genetic algorithms, next being validated with a long set of more than 50 days covering different weather conditions. It is worth to highlight the use of the developed model as a tool to analyze the influence of the temperature on the performance of microalgae cultures at large scale. As example, the annual variation of the performance of up to five different microalgae strains has been determined by computing the temperature index, thus the normalized value of performance of whatever microalgae at the real temperature with respect to that achievable at optimal temperature can be established. Results confirm that only strains tolerant to wide ranges of temperature can be efficiently produced all the year around in large scale outdoor raceway reactors without additional temperature control systems.X-ray microtomography (microCT) enables histological-scale 3D imaging of many types of biological samples, but it has yet to rival traditional histology for differentiation of tissue types and cell components. This report presents prima facie results indicating that a simple lead(II) acetate staining solution can impart preferential X-ray contrast to cell nuclei. While not strictly selective for nuclei, the staining reflects local cell-density differences. It can be applied in a single overnight treatment and does not require hematoxylin staining or drying of the sample. The stain is removable with EDTA, and it may enhance early calcifications. A basic protocol is given as a guide for further testing and optimization.The above article from the British Journal of Pharmacology, published online on 2 November 2020 in Wiley Online Library (wileyonlinelibrary.com), has been withdrawn by agreement between the journal's Editor-in-Chief and John Wiley &amp; Sons Ltd. The withdrawal has been agreed due to an error in the journal's editorial processes which resulted in the article being accepted before further revisions could be requested from the authors.Random growth hormone (GH) levels have been used in the neonate to investigate congenital growth hormone deficiency (GHD). The cut-off value for use in this diagnosis is yet to be established.
This is a retrospective chart review of all random GH levels obtained in neonates ?28days of age. Neonates were divided into three groups those diagnosed with congenital GHD, those at risk for GHD (ARF-GHD) and a non-growth hormone deficient (non-GHD) group. Mean GH levels for each group were compared, and ROC analysis was used to identify a cut-off for the diagnosis of GHD.
The study included 138 neonates with the mean age of 9.07±6.6days, and 65% of these were born at term gestation. Mean GH levels were lower in the GHD group (2.73±1.19ng/ml) as compared to the ARF-GHD (9.4±7.96ng/ml, p=.002) and non-GHD groups (14.86±14.42ng/ml, p=.027). GH values were not significantly different between non-GHD and ARF-GHD groups. ROC analysis identified a cut-off of serum random GH level of 4.5ng/ml that achieved 100% sensitivity and 83% specificity for the diagnosis of congenital GHD.
This study demonstrates that random GH levels obtained in the first 28days of life can be useful in diagnosing congenital GHD. Moreover, a diagnostic cut-off for congenital GHD using random GH levels was identified.
This study demonstrates that random GH levels obtained in the first 28 days of life can be useful in diagnosing congenital GHD. Moreover, a diagnostic cut-off for congenital GHD using random GH levels was identified.Pulmonary veno-occlusive disease (PVOD) is a rare disease characterized by the obstruction of small pulmonary veins leading to pulmonary hypertension. However, the mechanisms underlying pulmonary vessel occlusion remain largely unclear.
A mitomycin C (MMC)-induced PVOD rat model was used as in vivo animal model, and primarily cultured rat pulmonary microvascular endothelial cells (PMVECs) were used as in vitro cell model.
Our data suggested an endothelial-to-mesenchymal transition (EndoMT) may be present in the pulmonary microvessels isolated from either PVOD patients or MMC-induced PVOD rats. In comparison to the control vessels, vessels from both PVOD patients and PVOD rats had co-localized staining of specific endothelial marker von Willebrand factor (vWF) and mesenchymal marker α-smooth muscle actin (α-SMA), suggesting the presence of cells that co-express endothelial and mesenchymal markers. In both the lung tissues of MMC-induced PVOD rats and MMC-treated rat PMVECs there were decreased levels of endothelial markers (e.g. VE-cadherin and CD31) and increased mesenchymal markers (e.g. vimentin, fibronectin and α-SMA) were detected indicating EndoMT. Moreover, MMC-induced activation of the TGFβ/Smad3/Snail axis, while blocking this pathway with either selective Smad3 inhibitor (SIS3) or small interfering RNA (siRNA) against Smad3, dramatically abolished the MMC-induced EndoMT. Notably, treatment with SIS3 remarkably prevented the pathogenesis of MMC-induced PVOD in rats.
Our data indicated that targeted inhibition of Smad3 leads to a potential, novel strategy for PVOD therapy, likely by inhibiting the EndoMT in pulmonary microvasculature.
Our data indicated that targeted inhibition of Smad3 leads to a potential, novel strategy for PVOD therapy, likely by inhibiting the EndoMT in pulmonary microvasculature.